(DOCU) DocuSign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2561631068

DOCU: Signatures, Contracts, Documents, Management, Analytics, Software

DocuSign is a leader in digital transaction management, specializing in electronic signature solutions and contract lifecycle management. Their platform allows users to send, sign, and manage agreements across various devices, streamlining workflows for businesses of all sizes. Beyond e-signatures, DocuSign offers tools like Contract Lifecycle Management (CLM), which automates the entire agreement process from creation to archiving, and Document Generation, which simplifies the creation of custom agreements. Their integration with Salesforce, known as Gen for Salesforce, enables sales teams to generate agreements directly within Salesforce with minimal clicks.

The company also provides advanced features such as Identify, which verifies government-issued IDs for secure transactions, and Standards-Based Signatures, which support digitally certified signatures. DocuSign Monitor uses analytics to track account activity across web, mobile, and API channels, while their Notary product enables remote online notarization. Web Forms allow users to quickly draft agreements using pre-populated data, either from completed forms or external systems via APIs.

DocuSign has tailored solutions for specific industries, such as Rooms for Real Estate, which provides a digital platform for brokers and agents to manage real estate transactions. They also offer a FedRAMP-authorized version of their eSignature platform for U.S. federal agencies and life sciences modules that comply with regulatory requirements for electronic signatures. The company distributes its products through direct sales, partner-assisted sales, and digital self-service channels.

Founded in 2003 and headquartered in San Francisco, DocuSign has established itself as a key player in the digital transformation of document workflows. With a market capitalization of $18.28 billion and a P/E ratio of 18.77, the company is valued for its growth potential in the expanding market for digital transaction management. Its forward P/E of 23.98 reflects investor confidence in its future prospects. The stock trades on the NASDAQ under the ticker symbol DOCU.

Additional Sources for DOCU Stock

DOCU Stock Overview

Market Cap in USD 16,843m
Sector Technology
Industry Software - Application
GiC Sub-Industry Application Software
IPO / Inception 2018-04-27

DOCU Stock Ratings

Growth 5y -6.69%
Fundamental 86.9%
Dividend 0.0%
Rel. Strength 43.6
Analysts 3.04/5
Fair Price Momentum 79.31 USD
Fair Price DCF 102.95 USD

DOCU Dividends

No Dividends Paid

DOCU Growth Ratios

Growth Correlation 3m -70.1%
Growth Correlation 12m 78.5%
Growth Correlation 5y -66.8%
CAGR 5y -1.15%
CAGR/Max DD 5y -0.01
Sharpe Ratio 12m 0.44
Alpha 32.02
Beta 1.024
Volatility 43.12%
Current Volume 1504.1k
Average Volume 20d 2435.7k
What is the price of DOCU stocks?
As of March 31, 2025, the stock is trading at USD 83.18 with a total of 1,504,111 shares traded.
Over the past week, the price has changed by -6.54%, over one month by +2.34%, over three months by -9.29% and over the past year by +42.85%.
Is DocuSign a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, DocuSign (NASDAQ:DOCU) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 86.92 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCU as of March 2025 is 79.31. This means that DOCU is currently overvalued and has a potential downside of -4.65%.
Is DOCU a buy, sell or hold?
DocuSign has received a consensus analysts rating of 3.04. Therefor, it is recommend to hold DOCU.
  • Strong Buy: 2
  • Buy: 2
  • Hold: 16
  • Sell: 1
  • Strong Sell: 2
What are the forecast for DOCU stock price target?
According to ValueRays Forecast Model, DOCU DocuSign will be worth about 88.3 in March 2026. The stock is currently trading at 83.18. This means that the stock has a potential upside of +6.12%.
Issuer Forecast Upside
Wallstreet Target Price 95.2 14.4%
Analysts Target Price 95.9 15.3%
ValueRay Target Price 88.3 6.1%